Ritxumiab radiation unfolder trial pub med

doi: Crossref Medline ISI, Google ScholarДЎ4. Positron emission tomography score has greater prognostic significance than pretreatment risk stratification in early-stage Hodgkin lymphoma in the UK rapid study. Barrington SF, , Phillips EH, , Counsell N, , Hancock B, , Pettengell R, , Johnson P, , et al. doi: Crossref Medline ISI, Google ScholarДЎ3.

Cardiac mortality among 200 000 five-year survivors of cancer diagnosed at 15 to 39 years of age: the teenage and young adult cancer survivor study. Henson KE, , Reulen RC, , Winter DL, , Bright CJ, , Fidler MM, , Frobisher C, , et al. doi: Crossref Medline ISI, Google ScholarДЎ2. Second cancer risk up to 40 years after treatment for hodgkinвЂ™s lymphoma. Schaapveld M, , Aleman BMP, , van Eggermond AM, , Janus CPM, , Krol ADG, , van der Maazen RWM, , et al. doi: Crossref Medline ISI, Google ScholarДЎ1. Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial. Raemaekers JMM, , AndrГ© MPE, , Federico M, , Girinsky T, , Oumedaly R, , Brusamolino E, , et al. doi: (20)30601-X Crossref Medline ISI, Google ScholarДЎ0. PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial. Borchmann P, , PlГјtschow A, , Kobe C, , Greil R, , Meissner J, , Topp MS, , et al. doi: Crossref Medline ISI, Google ScholarД©. CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET. Straus DJ, , Jung S-H, , Pitcher B, , Kostakoglu L, , Grecula JC, , Hsi ED, , et al. doi: Crossref Medline ISI, Google ScholarДЁ. Positron emission Tomography-Guided treatment in early-stage favorable Hodgkin lymphoma: final results of the International, randomized phase III HD16 trial by the German Hodgkin Study Group. Fuchs M, , Goergen H, , Kobe C, , Kuhnert G, , Lohri A, , Greil R, , et al. doi: Crossref Medline ISI, Google ScholarД§. Early positron emission tomography Response-Adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC/LYSA/FIL H10 trial. AndrГ© MPE, , Girinsky T, , Federico M, , Reman O, , Fortpied C, , Gotti M, , et al. doi: Crossref Medline ISI, Google ScholarД¦. Results of a trial of PET-directed therapy for early-stage hodgkinвЂ™s lymphoma. Radford J, , Illidge T, , Counsell N, , Hancock B, , Pettengell R, , Johnson P, , et al. doi: Crossref Medline ISI, Google ScholarДҐ.

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Cheson BD, , Fisher RI, , Barrington SF, , Cavalli F, , Schwartz LH, , Zucca E, , et al. doi: Crossref Medline ISI, Google ScholarД¤. Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Barrington SF, , Qian W, , Somer EJ, , Franceschetto A, , Bagni B, , Brun E, , et al. doi: Crossref Medline ISI, Google ScholarДЈ. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on malignant lymphomas imaging Working group. Barrington SF, , Mikhaeel NG, , Kostakoglu L, , Meignan M, , Hutchings M, , MГјeller SP, , et al. doi: Crossref Medline ISI, Google ScholarДў. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging Subcommittee of international harmonization project in lymphoma. Juweid ME, , Stroobants S, , Hoekstra OS, , Mottaghy FM, , Dietlein M, , Guermazi A, , et al.

Ritxumiab radiation unfolder trial pub med